RECURRENT LEUKEMIA
Clinical trials for RECURRENT LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LEUKEMIA trials appear
Sign up with your email to follow new studies for RECURRENT LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for Tough-to-Treat blood cancers
Disease control OngoingThis is an early-stage study to find the safest dose of a new drug called tegavivint for adults with leukemia that has come back or stopped responding to standard treatments. The drug aims to block cancer cell growth, and researchers are testing it alone and with another drug, de…
Matched conditions: RECURRENT LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
The hidden burden: how Cancer's weight loss wears down patients and families
Knowledge-focused OngoingThis study aims to understand how often advanced cancer patients experience severe weight loss and loss of appetite, a condition called cachexia. Researchers are also measuring the emotional and psychological stress this causes for both the patients and their primary family careg…
Matched conditions: RECURRENT LEUKEMIA
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC